Olivier Bogillot

With over two decades of experience in the healthcare industry, I've dedicated my career to the pursuit of innovative and patient-centered solutions. I believe we all have a responsibility to ensure we are constantly evolving to meet the needs of the millions of people around the world who rely on our medicines.  In my current role as Head of North America General Medicines, I'm privileged to lead a diverse and talented team at Sanofi focused on serving the diabetes, cardiovascular and transplant communities. As the landscape of healthcare continues to evolve, I'm particularly passionate about leveraging cutting-edge technology and research to bring new medications to market, improving patient outcomes and driving the growth of our business. Prior to Sanofi, I held a variety of leadership roles at Merck KGaA, Amgen, and Bristol-Myers Squibb, where my responsibilities fell within the areas of market access in France and Europe. I gained extensive experience in pharmaceuticals, biotechnology and medical technology, and this background has given me a unique perspective on the industry, allowing me to approach challenges from multiple angles and develop creative solutions. I also currently sit on the Board of Directors of Leem (Les Entreprises du Médicament), chair the French Federation of Health Industries, and serve as an advisor for health, dependence and social policies for the Presidency of the French Republic.